213
Participants
Start Date
May 31, 2005
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
fludrocortisone acetate
Fludrocortisone acetate to a maximum of 0.2 mg daily Placebo to a maximum of 0.2 mg daily
Boston University, Boston
Vanderbilt University, Nashville
Virginia Cardiovascular Specialists, Richmond
University of Calgary, Faculty of Medicine, Calgary
Alberta Children's Hospital, Calgary
St. Boniface General Hospital, Winnipeg
Queen Elizabeth II, Halifax Infirmary, Halifax
McMaster University, Hamilton Health Sciences, Hamilton
Queen's University, Kingston
University of Western Ontario, London Health Sciences, London
University of Ottawa, Ottawa Heart Institute, Ottawa
St. Michael's Hospital, Toronto
Institut de Cardiologie de Montreal, Montreal
Hopital Sacre Coeur de Montreal, Montreal
Canadian Institutes of Health Research (CIHR)
OTHER_GOV
University of Calgary
OTHER